Phase 2 Study to Assess the Safety and Efficacy of ANG003
for Exocrine Pancreatic Insufficiency (EPI)
26 locations incl. Long Beach
Sponsor: Anagram Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT07450547·Phase 2·Recruiting·Listed Mar 2026
Massachusetts General Hospital.
Clinical research site in Boston, Massachusetts · 55 FRUIT ST, CARDIOLOGY, GRB 800, MS 843, BOSTON, MA 02114-2621 · (617) 724-1935 · Website
Part of Massachusetts General Hospital
As of July 2026, 607 paid clinical trials are recruiting at Massachusetts General Hospital. in Boston, Massachusetts. Active studies at this site cover conditions such as Breast Cancer, Heart Failure and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Massachusetts General Hospital. (607)
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for Hepatitis
48 locations incl. Birmingham
Sponsor: Bausch Health Americas, Inc.
Sex: All·Age: 18+
Code: NCT07428538·Phase 3·Recruiting·Listed Feb 2026
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
67 locations incl. Tucson
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
for Breast Neoplasms
28 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: Female·Age: 18+
Code: NCT07287098·Phase 2·Recruiting·Listed Dec 2025
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
29 locations incl. Birmingham
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07266441·Phase 2·Recruiting·Listed Dec 2025
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for Pancreatic Cancer
29 locations incl. Los Angeles
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
62 locations incl. Huntsville
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for Transthyretin Amyloid Cardiomyopathy (ATTR CM)
60 locations incl. Phoenix
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07207811·Phase 3·Recruiting·Listed Oct 2025
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for Parkinson's Disease
46 locations incl. Birmingham
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 85
Code: NCT07174310·Phase 3·Recruiting·Listed Sep 2025
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
169 locations incl. Daphne
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for Triple Negative Breast Cancer
124 locations incl. Birmingham
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for End Stage Kidney Disease
147 locations incl. Decatur
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT05485961·Phase 2, Phase 3·Recruiting·Listed Aug 2022
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
for Atrial Fibrillation (AF)
20 locations incl. Birmingham
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT07187115·Recruiting·Listed Sep 2025
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for Carcinoma, Non-Small Cell Lung
104 locations incl. Anchorage
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04389632·Phase 1·Recruiting·Listed May 2020
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for Diabetes Mellitus, Type 2
123 locations incl. Chandler
Sponsor: Cleerly, Inc.
Sex: All·Age: 55+·Accepts healthy volunteers
Code: NCT06112418·Recruiting·Listed Nov 2023
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for Moderate Aortic Valve Stenosis
69 locations incl. Birmingham
Sponsor: Kardigan, Inc.
Sex: All·Age: 50+
Code: NCT07001800·Phase 2, Phase 3·Recruiting·Listed Jun 2025
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
for Hidradenitis Suppurativa
78 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 12+
Code: NCT05889182·Phase 3·Recruiting·Listed Jun 2023
Assessment of CCM in HF With Higher Ejection Fraction
for Heart Failure
76 locations incl. Birmingham
Sponsor: Impulse Dynamics
Sex: All·Age: 18+
Code: NCT05064709·Recruiting·Listed Oct 2021
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for NonSegmental Vitiligo
69 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 2 - 11
Code: NCT06548360·Phase 3·Recruiting·Listed Aug 2024
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
38 locations incl. Mobile
Sponsor: Incyte Corporation
Sex: Female·Age: 18 - 99
Code: NCT07023627·Phase 2·Recruiting·Listed Jun 2025
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for Large B-cell Lymphoma
60 locations incl. Gilbert
Sponsor: Allogene Therapeutics
Sex: All·Age: 18+
Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for Primary Biliary Cholangitis
51 locations incl. Birmingham
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT06051617·Phase 3·Recruiting·Listed Sep 2023
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
for Urinary Bladder Neoplasms
41 locations incl. Tucson
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT05614739·Phase 1·Recruiting·Listed Nov 2022
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for Non-Small Cell Lung Cancer
50 locations incl. Anchorage
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06793215·Phase 3·Recruiting·Listed Jan 2025
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for Advanced Solid Tumor
24 locations incl. Tucson
Sponsor: Synthekine
Sex: All·Age: 18+
Code: NCT05098132·Phase 1, Phase 2·Recruiting·Listed Oct 2021
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
for High Grade Epithelial Ovarian Cancer
37 locations incl. Phoenix
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT05579366·Phase 1, Phase 2·Recruiting·Listed Oct 2022
ELEVATE High-Risk PCI Pivotal Study
for High-Risk Percutaneous Coronary Intervention (High-risk PCI)
33 locations incl. Phoenix
Sponsor: Magenta Medical Ltd.
Sex: All·Age: 18 - 88
Code: NCT07001332·Recruiting·Listed Jun 2025
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for Carcinoma, Non-Small-Cell Lung
48 locations incl. Gilbert
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06623422·Phase 3·Recruiting·Listed Oct 2024
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for Multiple Myeloma
28 locations incl. Phoenix
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05201781·Phase 4·Recruiting·Listed Jan 2022
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for Breast Neoplasms
38 locations incl. Hot Springs
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT06926868·Phase 2, Phase 3·Recruiting·Listed Apr 2025
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
for Antineutrophil Cytoplasmic Antibody-associated Vasculitis
57 locations incl. Scottsdale
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT06072482·Phase 4·Recruiting·Listed Oct 2023
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
for Melanoma
58 locations incl. Birmingham
Sponsor: Pfizer
Sex: All·Age: 16+
Code: NCT05538130·Phase 1·Recruiting·Listed Sep 2022
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for Coronary Arterial Disease (CAD)
42 locations incl. La Jolla
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT06959524·Recruiting·Listed May 2025
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
for Bronchiectasis
57 locations incl. Anchorage
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT06872892·Phase 3·Recruiting·Listed Mar 2025
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
for Tricuspid Regurgitation
46 locations incl. Irvine
Sponsor: Edwards Lifesciences
Sex: All·Age: 18+
Code: NCT04097145·Recruiting·Listed Sep 2019
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
for Mitral Valve Regurgitation
69 locations incl. Birmingham
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18+
Code: NCT03242642·Recruiting·Listed Aug 2017
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for Interstitial Lung Diseases
33 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06806592·Phase 3·Recruiting·Listed Feb 2025
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for Glioma
42 locations incl. Birmingham
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
for Progressive Pulmonary Fibrosis
74 locations incl. Birmingham
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT05943535·Phase 3·Recruiting·Listed Jul 2023
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
for Pancreatic Ductal Adenocarcinoma
25 locations incl. Duarte
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06586515·Phase 1·Recruiting·Listed Sep 2024
Showing the 40 most relevant of 607 recruiting trials at this site. Browse all with filters →
More research sites in Boston
- Massachusetts General Hospital (694 trials)
- Brigham and Women's Hospital (346 trials)
- Dana-Farber Cancer Institute (341 trials)
- Beth Israel Deaconess Medical Center (265 trials)
- Boston Children's Hospital (259 trials)
- Dana Farber Cancer Institute (221 trials)
- Tufts Medical Center (107 trials)
- Boston Medical Center (94 trials)
- Massachusetts General Hospital Cancer Center (57 trials)
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA (28 trials)
Explore more
Paid clinical trials in Boston, MA · Massachusetts clinical trials